$80,000 of UNITED THERAPEUTICS CORPORATION lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to organs and xenotransplantation."
You can find more data on corporate lobbying on Quiver Quantitative.
UTHR Insider Trading Activity
UTHR insiders have traded $UTHR stock on the open market 1300 times in the past 6 months. Of those trades, 0 have been purchases and 1300 have been sales.
Here’s a breakdown of recent trading of $UTHR stock by insiders over the last 6 months:
- MARTINE A ROTHBLATT (Chairperson & CEO) has made 0 purchases and 891 sales selling 798,075 shares for an estimated $437,632,804.
- JAMES EDGEMOND (CFO AND TREASURER) has made 0 purchases and 272 sales selling 238,750 shares for an estimated $134,032,698.
- PAUL A MAHON (EVP & GENERAL COUNSEL) has made 0 purchases and 85 sales selling 83,000 shares for an estimated $44,853,247.
- MICHAEL BENKOWITZ (PRESIDENT AND COO) has made 0 purchases and 34 sales selling 81,940 shares for an estimated $38,569,925.
- RAY KURZWEIL sold 4,910 shares for an estimated $2,401,088
- CHRISTOPHER PATUSKY has made 0 purchases and 2 sales selling 3,910 shares for an estimated $2,234,670.
- TOMMY G THOMPSON has made 0 purchases and 4 sales selling 4,000 shares for an estimated $2,057,171.
- CHRISTOPHER CAUSEY has made 0 purchases and 3 sales selling 2,320 shares for an estimated $1,315,835.
- JUDY D. OLIAN has made 0 purchases and 4 sales selling 800 shares for an estimated $416,998.
- JAN MALCOLM has made 0 purchases and 3 sales selling 420 shares for an estimated $226,683.
- NILDA MESA sold 258 shares for an estimated $150,139
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
UTHR Hedge Fund Activity
We have seen 365 institutional investors add shares of UTHR stock to their portfolio, and 357 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AQR CAPITAL MANAGEMENT LLC removed 455,473 shares (-35.5%) from their portfolio in Q1 2026, for an estimated $265,627,298
- BLACKROCK, INC. added 228,883 shares (+4.4%) to their portfolio in Q1 2026, for an estimated $133,482,276
- JANE STREET GROUP, LLC removed 214,061 shares (-98.7%) from their portfolio in Q1 2026, for an estimated $124,838,234
- WELLINGTON MANAGEMENT GROUP LLP removed 177,245 shares (-7.3%) from their portfolio in Q1 2026, for an estimated $103,367,511
- CITADEL ADVISORS LLC added 173,479 shares (+92.7%) to their portfolio in Q1 2026, for an estimated $101,171,218
- FIFTH THIRD BANCORP added 164,519 shares (+35842.9%) to their portfolio in Q1 2026, for an estimated $95,945,835
- WICK CAPITAL PARTNERS, LLC removed 155,259 shares (-99.7%) from their portfolio in Q1 2026, for an estimated $90,545,496
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
UTHR Price Targets
Multiple analysts have issued price targets for $UTHR recently. We have seen 9 analysts offer price targets for $UTHR in the last 6 months, with a median target of $660.0.
Here are some recent targets:
- Lisa Walter from RBC Capital set a target price of $704.0 on 07/07/2026
- Benjamin Burnett from Wells Fargo set a target price of $738.0 on 05/07/2026
- Terence Flynn from Morgan Stanley set a target price of $519.0 on 04/10/2026
- Greg Harrison from B of A Securities set a target price of $626.0 on 03/31/2026
- Andrew S. Fein from HC Wainwright & Co. set a target price of $660.0 on 03/31/2026
- Joseph Thome from TD Cowen set a target price of $660.0 on 03/30/2026
- Olivia Brayer Saunders from Cantor Fitzgerald set a target price of $625.0 on 03/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
